APA (7th ed.) Citation

Y, C., JH, W., H, K., Y, H., Y, K., & H, L. (2025). Country Contribution to Investigators of Pivotal Clinical Trials and Their Primary Publications of New Drugs Approved by the US Food and Drug Administration, 2012-2021. Clinical pharmacology and therapeutics, 117(4), 1131. https://doi.org/10.1002/cpt.3589

Chicago Style (17th ed.) Citation

Y, Choi, Won JH, Kim H, Hong Y, Kim Y, and Lee H. "Country Contribution to Investigators of Pivotal Clinical Trials and Their Primary Publications of New Drugs Approved by the US Food and Drug Administration, 2012-2021." Clinical Pharmacology and Therapeutics 117, no. 4 (2025): 1131. https://doi.org/10.1002/cpt.3589.

MLA (9th ed.) Citation

Y, Choi, et al. "Country Contribution to Investigators of Pivotal Clinical Trials and Their Primary Publications of New Drugs Approved by the US Food and Drug Administration, 2012-2021." Clinical Pharmacology and Therapeutics, vol. 117, no. 4, 2025, p. 1131, https://doi.org/10.1002/cpt.3589.